Excel Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-06-2024
- Paid Up Capital ₹ 1.00 M
as on 18-06-2024
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.71 Cr
as on 18-06-2024
- Revenue -17.90%
(FY 2023)
- Profit 53.27%
(FY 2023)
- Ebitda 195.46%
(FY 2023)
- Net Worth 20.33%
(FY 2023)
- Total Assets 1.41%
(FY 2023)
About Excel Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.71 Cr.
Sukanya Chandra, Shila Bose, Ashis Bose, and One other member serve as directors at the Company.
- CIN/LLPIN
U24219WB2000PTC092280
- Company No.
092280
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Excel Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashis Bose  | Managing Director | 14-Aug-2000 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sukanya Chandra | Director | 02-May-2023 | Current |
| Shila Bose | Director | 14-Aug-2000 | Current |
| Amaresh Basu | Director | 15-May-2013 | Current |
Financial Performance of Excel Biotech.
Excel Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.9% decrease. The company also saw a substantial improvement in profitability, with a 53.27% increase in profit. The company's net worth Soared by an impressive increase of 20.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excel Biotech?
In 2023, Excel Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Jun 2023 | ₹3.80 M | Open |
Hdfc Bank Limited Creation Date: 02 May 2023 | ₹0.45 M | Open |
Hdfc Bank Limited Creation Date: 19 Apr 2023 | ₹0.60 M | Open |
How Many Employees Work at Excel Biotech?
Unlock and access historical data on people associated with Excel Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excel Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excel Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
